Epoprostenol sodium
USP/1237600 - United States Pharmacopeia (USP) Reference Standard
Synonym: Prostaglandin I2 sodium salt; (5Z,9α,11α,13E,15S)-6,9-Epoxy-11,15-dihydroxyprosta-5,13-dien-1-oic acid sodium salt; Epoprostenol sodium salt; PGI2-Na; Prostacyclin sodium salt
CAS Number: 61849-14-7
Empirical Formula (Hill Notation): C20H31NaO5
Molecular Weight: 374.45
Linear Formula: C20H31NaO5
Product Type: Chemical
API family | epoprostenol |
application(s) | pharmaceutical (small molecule) |
format | neat |
grade | pharmaceutical primary standard |
InChI | 1S/C20H32O5.Na/c1-2-3-4-8 |
InChI key | OURCVRVJQMLUNA-QFDVFERUSA |
manufacturer/tradename | USP |
SMILES string | CCCCC[C@H](O)/C=C/[C@H]1[ |
storage temp. | −20°C |
Analysis Note: | These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. |
Application: | Epoprostenol sodium USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia. |
Biochem/physiol Actions: | Prostacyclin therapy improves hemodynamics in pulmonary arterial hypertension. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia ![]() ![]() |
Other Notes: | Sales restrictions may apply. |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | −20°C |
UNSPSC | 41116107 |